Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 73

BillFederalSenateIn Committee
A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
About This Bill
Committee
Latest Action · January 10, 2019
Read twice and referred to the Committee on Finance.
Congress
116th (2019–2021)
Introduced
January 10, 2019
Sponsor
Sen. Jeanne ShaheenD
Cosponsors (22)
20D 0R
View PDF ↗

Summary

Highlight any text to annotate
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.